Kayne Anderson Rudnick Investment Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.8K | Sell |
220
-15
| -6% | -$1.34K | ﹤0.01% | 650 |
|
|
2025
Q4 | $18.6K | Hold |
235
| – | – | ﹤0.01% | 671 |
|
|
2025
Q3 | $18.8K | Sell |
235
-28
| -11% | -$2.39K | ﹤0.01% | 678 |
|
|
2025
Q2 | $23.9K | Sell |
263
-15
| -5% | -$1.37K | ﹤0.01% | 661 |
|
|
2025
Q1 | $26K | Sell |
278
-27
| -9% | -$2.42K | ﹤0.01% | 631 |
|
|
2024
Q4 | $27.7K | Sell |
305
-16
| -5% | -$1.53K | ﹤0.01% | 601 |
|
|
2024
Q3 | $33.3K | Sell |
321
-39
| -11% | -$3.98K | ﹤0.01% | 579 |
|
|
2024
Q2 | $34.9K | Sell |
360
-10
| -3% | -$922 | ﹤0.01% | 558 |
|
|
2024
Q1 | $33.3K | Sell |
370
-24
| -6% | -$2.03K | ﹤0.01% | 564 |
|
|
2023
Q4 | $31.4K | Sell |
394
-102
| -21% | -$7.67K | ﹤0.01% | 550 |
|
|
2023
Q3 | $35.3K | Buy |
496
+291
| +142% | +$21.8K | ﹤0.01% | 528 |
|
|
2023
Q2 | $15.8K | Buy |
205
+5
| +3% | +$387 | ﹤0.01% | 572 |
|
|
2023
Q1 | $15K | Hold |
200
| – | – | ﹤0.01% | 552 |
|
|
2022
Q4 | $15.8K | Hold |
200
| – | – | ﹤0.01% | 564 |
|
|
2022
Q3 | $14K | Hold |
200
| – | – | ﹤0.01% | 545 |
|
|
2022
Q2 | $16K | Hold |
200
| – | – | ﹤0.01% | 526 |
|
|
2022
Q1 | $15K | Hold |
200
| – | – | ﹤0.01% | 515 |
|
|
2021
Q4 | $17K | Buy |
+200
| New | +$15.6K | ﹤0.01% | 519 |
|
|
2020
Q1 | – | Sell |
-29
| Closed | -$2K | – | 622 |
|
|
2019
Q4 | $2K | Buy |
+29
| New | +$1.98K | ﹤0.01% | 557 |
|
|
2017
Q1 | – | Sell |
-201,440
| Closed | -$13.2M | – | 335 |
|
|
2016
Q4 | $13.2M | Sell |
201,440
-6,622
| -3% | -$454K | 0.16% | 148 |
|
|
2016
Q3 | $15.4M | Buy |
208,062
+60,600
| +41% | +$4.48M | 0.19% | 145 |
|
|
2016
Q2 | $10.8M | Sell |
147,462
-59,027
| -29% | -$4.2M | 0.16% | 143 |
|
|
2016
Q1 | $14.6M | Sell |
206,489
-4,029
| -2% | -$268K | 0.24% | 120 |
|
|
2015
Q4 | $14M | Sell |
210,518
-3,155
| -1% | -$210K | 0.23% | 118 |
|
|
2015
Q3 | $13.6M | Sell |
213,673
-4,060
| -2% | -$265K | 0.23% | 112 |
|
|
2015
Q2 | $14.2M | Sell |
217,733
-3,548
| -2% | -$241K | 0.22% | 125 |
|
|
2015
Q1 | $15.3M | Sell |
221,281
-4,345
| -2% | -$300K | 0.24% | 116 |
|
|
2014
Q4 | $15.6M | Sell |
225,626
-116,613
| -34% | -$7.88M | 0.26% | 105 |
|
|
2014
Q3 | $22.3M | Sell |
342,239
-7,969
| -2% | -$526K | 0.4% | 77 |
|
|
2014
Q2 | $23.9M | Sell |
350,208
-3,935
| -1% | -$264K | 0.41% | 66 |
|
|
2014
Q1 | $23M | Sell |
354,143
-6,470
| -2% | -$408K | 0.4% | 69 |
|
|
2013
Q4 | $23.5M | Sell |
360,613
-5,754
| -2% | -$368K | 0.39% | 68 |
|
|
2013
Q3 | $21.7M | Sell |
366,367
-5,229
| -1% | -$310K | 0.41% | 66 |
|
|
2013
Q2 | $21.3M | Buy |
+371,596
| New | +$22.1M | 0.43% | 64 |
|
Other funds holding CL
VCM
DAM
VPM
Kayne Anderson Rudnick Investment Management's CL Position: Q1 2026 in Review
Kayne Anderson Rudnick Investment Management reduced its Colgate-Palmolive (CL) stake by 6.4% in Q1 2026, selling an estimated $1.34K and leaving 220 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #650.
Kayne Anderson Rudnick Investment Management first reported a position in CL in Q2 2013 and has held it in 34 quarters since. The position peaked at $23.9M in Q2 2014. 1,951 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Kayne Anderson Rudnick Investment Management held 220 shares of Colgate-Palmolive worth $18.8K as of Q1 2026.
- Kayne Anderson Rudnick Investment Management sold 15 Colgate-Palmolive shares in Q1 2026, an estimated $1.34K.
- Colgate-Palmolive made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q1 2026, its #650 holding.
- Kayne Anderson Rudnick Investment Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 34 quarters since.
- Kayne Anderson Rudnick Investment Management's Colgate-Palmolive position peaked at $23.9M in Q2 2014.
- 1,951 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.